• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

66.26 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
LivaNova (LIVN) Q2 2025 Earnings Transcript ↗
May 06, 2026
LivaNova (LIVN) Q2 2025 Earnings Transcript 
Via The Motley Fool
Topics Supply Chain
News headline image
LivaNova (LIVN) Q3 2025 Earnings Transcript ↗
May 06, 2026
LivaNova (LIVN) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
LivaNova (LIVN) Q1 2026 Earnings Transcript ↗
May 06, 2026
LivaNova (LIVN) Q1 2026 Earnings Transcript 
Via The Motley Fool
LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidance ↗
May 06, 2026
Via Chartmill
LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlook ↗
February 25, 2026
Via Chartmill
News headline image
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
May 06, 2026
From LivaNova PLC
Via Business Wire
News headline image
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
April 20, 2026
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Announce First-Quarter 2026 Results
March 25, 2026
From LivaNova PLC
Via Business Wire
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
 
Via Benzinga
News headline image
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
March 19, 2026
From LivaNova PLC
Via Business Wire
News headline image
LivaNova (LIVN) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
LivaNova (LIVN) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
February 25, 2026
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
January 20, 2026
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present at J.P. Morgan Healthcare Conference in January
December 23, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
December 03, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
December 02, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present at Piper Sandler Healthcare Conference in December
November 25, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 24, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
November 12, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
November 05, 2025
LivaNova (LIVN) beat Q3 2025 earnings and revenue estimates, raising its full-year guidance on strong performance across its Cardiopulmonary and Neuromodulation segments. 
Via Chartmill
News headline image
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
November 05, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present at Wolfe Research Healthcare Conference in November
October 23, 2025
From LivaNova PLC
Via Business Wire
News headline image
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
October 13, 2025
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the... 
Via MarketMinute
News headline image
LivaNova to Announce Third-Quarter 2025 Results
October 08, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
October 07, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Appoints Donald Zurbay as a New Director
September 04, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Host Investor Day on November 12, 2025
August 25, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
August 22, 2025
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Launches Essenz Perfusion System in China
August 18, 2025
From LivaNova PLC
Via Business Wire
News headline image
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday ↗
August 06, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap